Yumin Fu
Hefei, 230001, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Corrigendum to 'Tumor-derived CD109 orchestrates reprogramming of tumor-associated macrophages to dampen immune response' (J Hepatol 2025 [946-958]).
Journal: Journal of hepatology
Published: October 28, 2025
BCAT1 inhibits crotonate-related epigenetic modulation of metabolic genes in tumor-associated macrophages to counter immunosuppression.
Journal: Nature communications
Published: September 15, 2025
Gd-EOB-DTPA-Enhanced Magnetic Resonance Imaging for Predicting Immunotherapy Response in Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
Journal: Liver cancer
Published: August 02, 2025
Exploring the Interplay of Diet, Obesity, Immune Function, and Cancer.
Journal: Cancer discovery
Published: August 06, 2024
Tumor-derived CD109 orchestrates reprogramming of tumor-associated macrophages to dampen immune response.
Journal: Journal of hepatology
Published: July 08, 2024
VCP downstream metabolite glycerol-3-phosphate (G3P) inhibits CD8+T cells function in the HCC microenvironment.
Journal: Signal transduction and targeted therapy
Published: June 29, 2024
Exploring the role of the immune microenvironment in hepatocellular carcinoma: Implications for immunotherapy and drug resistance.
Journal: eLife
Published: January 17, 2024
A STT3A-dependent PD-L1 glycosylation modification mediated by GMPS drives tumor immune evasion in hepatocellular carcinoma.
Journal: Cell death and differentiation
Published: January 16, 2024
Showing 1-9 of 9
Last Updated: 09/26/2026